≡ Risteys
R13

Documentation Changelog GitHub Contact & Feedback
info icon

Toxic effect of corrosive substances

Endpoint Browser

ST19_TOXIC_EFFECT_CORROSIVE_SUBST

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — T54
  • Cause of death: ICD-10 — T54

2 out of 7 registries used, show all original rules.

197

4. Check minimum number of events

None

197

5. Include endpoints

None

197

6. Filter based on genotype QC (FinnGen only)

190

Control definitions (FinnGen only)

Control exclude
ST19_TOXIC_EFFEC_SUBST_CHIEF_NONME_SOURCE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
T5[1-9]|T6[0-5]
Name in latin
Effectus toxicus substantiarum corrosivarum

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 190 93 97
Unadjusted period prevalence (%) 0.04 0.03 0.04
Median age at first event (years) 43.36 40.26 46.34

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
197
Matched controls
1970
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
T54.3
ICD-10 Finland
Toxic effect: Corrosive alkalis and alkali-like substances
+∞
141.2
118
*
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
26.8
66.6
49
24
X49
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances
809.7
62.4
58
*
T54.2
ICD-10 Finland
Toxic effect: Corrosive acids and acid-like substances
+∞
45.6
42
*
T36
ICD-10 Finland
Poisoning by systemic antibiotics
13.4
39.5
41
38
T54.9
ICD-10 Finland
Toxic effect: Corrosive substance, unspecified
+∞
26.7
25
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
5.4
24.7
61
150
N05AA02
ATC
levomepromazine; systemic
9.4
21.9
28
34
N05AH03
ATC
olanzapine; systemic
6.1
21.9
44
89
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
5.7
19.8
42
89
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.0
19.3
77
270
N05AH04
ATC
quetiapine; oral
4.1
18.8
73
250
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
5.5
18.0
39
84
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
25.8
16.9
23
10
T28.6
ICD-10 Finland
Corrosion of oesophagus
185.0
16.8
17
*
N05AX08
ATC
risperidone; systemic
5.1
16.6
40
94
N03AG01
ATC
valproic acid; systemic, rectal
5.9
16.1
32
63
X59
ICD-10 Finland
Exposure to unspecified factor
3.7
15.2
65
234
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
27.6
15.0
20
8
N03AX09
ATC
lamotrigine; oral
6.0
14.7
28
53
N05BA04
ATC
oxazepam; oral
3.4
14.7
73
289
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
5.1
13.9
32
72
N05AX12
ATC
aripiprazole; systemic
5.7
13.8
28
56
N05BA01
ATC
diazepam; systemic, rectal
4.0
12.9
42
124
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
17.0
12.9
20
13
N05BA06
ATC
lorazepam; systemic, sublingual
5.8
12.9
25
48
T54.1
ICD-10 Finland
Toxic effect: Other corrosive organic compounds
+∞
12.6
12
*
N03AX16
ATC
[U] pregabalin
3.3
12.1
58
221
N05AF03
ATC
chlorprothixene; systemic
12.2
11.9
21
19
N05CD07
ATC
temazepam; oral
4.5
11.7
31
78
AA1AD
NOMESCO Finland
CT of head and brain
3.1
11.4
61
248
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
10.5
10.5
20
21
N03AE01
ATC
clonazepam; systemic
5.2
10.5
23
49
SPAT1307
SPAT
Psychosocial counselling and guidance
4.2
10.5
30
80
A02BC02
ATC
pantoprazole; systemic
2.8
10.5
136
868
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.9
10.3
34
101
Y19
ICD-10 Finland
Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent
42.4
10.1
12
*
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
27.7
9.9
13
5
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
4.9
9.8
23
52
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
3.9
9.8
32
94
N06AX11
ATC
mirtazapine; oral
2.6
9.8
83
426
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.4
9.5
38
128
Z72.8
ICD-10 Finland
Other problems related to lifestyle
104.9
9.5
10
*
Z91.5
ICD-10 Finland
Personal history of self-harm
104.9
9.5
10
*
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
3.2
9.3
43
159
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
4.6
9.2
23
55
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
8.9
88
482
N06AB03
ATC
fluoxetine; oral
3.4
8.8
36
123
X58
ICD-10 Finland
Exposure to other specified factors
3.1
8.7
43
165
X78
ICD-10 Finland
Intentional self-harm by sharp object
21.2
8.6
12
6
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
5.0
8.5
19
41
N05CF01
ATC
zopiclone; oral
2.6
8.5
68
335
N06AX16
ATC
venlafaxine; oral
3.0
8.5
45
179
F60.9
ICD-10 Finland
Personality disorder, unspecified
11.5
8.5
15
14
R11
ICD-10 Finland
Nausea and vomiting
3.5
8.4
31
99
W19
ICD-10 Finland
Unspecified fall
3.7
8.2
28
85
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.0
8.1
18
39
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.1
7.9
38
143
K10.3
ICD-10 Finland
Alveolitis of jaws
4.3
7.8
21
53
S06.0
ICD-10 Finland
Concussion
3.1
7.8
36
132
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.5
7.8
64
318
ZY000
NOMESCO Finland
Hospital inpatient
12.5
7.7
13
11
F29
ICD-10 Finland
Unspecified nonorganic psychosis
4.2
7.7
21
54
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
3.0
7.6
37
140
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
4.2
7.5
21
55
S05.8
ICD-10 Finland
Other injuries of eye and orbit
+∞
7.3
7
*
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
4.8
7.3
17
38
N05AN01
ATC
lithium; oral
7.0
7.3
17
26
N06AB04
ATC
citalopram; systemic
2.7
7.2
46
201
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.8
7.2
41
169
R07.4
ICD-10 Finland
Chest pain, unspecified
2.5
7.0
57
280
R33
ICD-10 Finland
Retention of urine
4.4
7.0
18
44
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
4.4
7.0
18
44
N03AX12
ATC
[U] gabapentin; oral
2.8
7.0
39
159
W44
ICD-10 Finland
Foreign body entering into or through eye or natural orifice
8.8
7.0
14
17
R42
ICD-10 Finland
Dizziness and giddiness
2.7
6.9
43
185
A06AC01
ATC
ispaghula (psylla seeds); oral
2.5
6.8
49
227
IAB08
NOMESCO Finland
Consultation concerning a patient who has attempted suicide
41.5
6.8
8
*
SPAT1301
SPAT
No procedures
2.3
6.8
66
351
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
23.4
6.7
9
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.6
6.7
47
215
P29
ICPC
Psychological sympt/compl other
3.0
6.7
31
114
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
7.4
6.3
14
20
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
3.7
6.3
21
62
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
6.7
6.3
15
24
T28.5
ICD-10 Finland
Corrosion of mouth and pharynx
+∞
6.3
6
*
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
27.6
6.3
8
*
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.2
6.3
67
369
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.5
6.2
44
202
C07AA05
ATC
propranolol; systemic
2.3
6.2
56
287
SPAT1263
SPAT
Sampling
2.1
6.2
89
551
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.5
6.1
22
69
J01MA02
ATC
ciprofloxacin; systemic
2.2
6.1
75
437
SPAT1252
SPAT
Overall medication plan or its review
4.3
6.0
16
40

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
73
310
3.15
12.81
4.9
4.0
—
—
—
0
0
27
68
4.44
10.15
6.9
8.6
24.82
24.40
mmol/l
0.25
27
68
95
525
2.56
9.54
12.7
12.2
1.13
1.20
inr
0.55
41
178
86
455
2.58
9.44
4.2
3.6
40.11
36.11
ng/l
0.06
56
268
84
441
2.58
9.36
4.4
2.8
53.09
55.23
u/l
0.33
79
409
22
51
4.73
9.13
8.0
14.4
25.10
24.18
mmol/l
0.91
22
51
46
181
3.01
8.88
1.9
1.7
1200.74
1161.69
nmol/l
0.12
37
144
64
305
2.63
8.58
1.6
1.9
0.59
1.01
mg/l
1.97
43
216
36
129
3.19
8.12
7.3
9.1
0.98
1.01
mmol/l
0.02
31
105
18
26
7.50
7.98
3.4
4.5
—
—
—
0
0
15
16
10.04
7.93
4.5
2.9
2.03
1.68
mmol/l
0.44
15
16
100
602
2.34
7.92
7.4
6.9
1.21
1.21
mmol/l
0.59
90
516
16
21
8.19
7.55
5.1
3.4
16.87
17.11
%
—
11
8
120
791
2.32
7.55
7.0
5.8
1.92
1.86
e9/l
0.48
107
713
20
50
4.34
7.55
8.4
2.8
—
—
—
0
0
15
18
8.92
7.47
3.1
2.4
—
—
—
0
0
51
234
2.59
7.27
4.3
3.0
247.54
146.44
ng/l
0.18
28
147
115
759
2.24
7.03
6.6
5.7
0.58
0.55
e9/l
0.64
100
672
115
760
2.23
6.99
6.9
5.7
0.04
0.04
e9/l
0.28
98
672
113
742
2.23
6.98
7.3
5.6
28.52
29.02
%
0.16
108
707
112
738
2.20
6.79
7.2
5.3
56.84
56.26
%
0.18
107
702
30
107
3.13
6.78
7.9
9.0
—
—
—
0
0
68
367
2.30
6.74
4.0
2.4
—
—
—
0
0
109
715
2.17
6.63
8.0
6.5
—
—
—
0
0
25
81
3.39
6.58
4.3
2.6
7.42
7.42
ph
—
8
7
39
164
2.72
6.56
1.3
1.3
—
—
—
0
0
36
146
2.79
6.48
7.2
8.2
104.61
103.79
mmol/l
0.39
36
146
69
380
2.26
6.48
3.6
3.9
7.40
7.41
ph
0.50
21
69
25
82
3.35
6.46
8.3
3.1
—
—
—
0
0
140
1027
2.26
6.26
5.2
3.9
—
—
—
0
0
149
1127
2.32
6.10
9.0
7.3
79.42
75.90
u/l
0.49
142
1058
115
787
2.11
6.08
7.7
6.0
0.20
0.19
e9/l
0.35
103
705
73
422
2.16
6.01
3.0
2.1
—
—
—
0
0
107
715
2.09
6.00
7.8
5.9
8.15
8.46
%
0.51
102
678
52
262
2.34
5.96
3.3
2.7
537.66
556.85
mosm/kgh2o
0.22
44
224
73
425
2.14
5.88
4.1
2.9
14.28
202.63
e6/l
0.66
60
325
105
711
2.02
5.53
7.5
5.6
2.59
2.87
%
0.66
99
670
78
477
2.05
5.44
1.9
1.7
90.86
97.56
pmol/l
0.66
39
257
102
687
2.01
5.42
7.8
5.6
0.67
0.69
%
0.09
96
643
5
0
+∞
5.23
1.0
0.0
—
—
mmol/l
—
0
0
11
15
7.69
5.22
3.9
1.9
—
—
—
0
0
123
895
2.00
5.14
12.0
9.1
4.44
3.99
e9/l
1.19
112
781
14
28
5.30
5.05
5.9
4.3
5.17
5.01
kpa
0.37
14
28
14
28
5.30
5.05
5.9
4.3
9.13
9.61
kpa
0.38
14
28
53
289
2.14
4.94
3.0
2.5
5.88
7.43
e6/l
0.21
47
262
149
1170
2.12
4.92
4.9
3.6
14.37
14.64
pmol/l
0.65
139
1076
10
13
8.03
4.91
13.0
9.8
0.70
0.65
mmol/l
—
10
13
64
381
2.01
4.70
4.0
2.9
0.20
0.44
e6/l
0.72
51
286
26
105
2.70
4.69
3.2
2.4
0.19
0.23
g/l
2.22
26
98
34
158
2.39
4.61
1.5
1.4
—
—
—
0
0
52
289
2.09
4.59
1.4
1.4
17.40
21.28
nmol/l
1.64
47
251
19
65
3.13
4.58
9.4
12.8
94.47
93.82
%
0.29
19
65
104
738
1.87
4.44
4.6
3.2
0.00
0.00
estimate
-0.00
29
139
77
499
1.89
4.35
4.7
3.4
111.90
90.31
e6/l
0.10
60
346
18
62
3.09
4.30
12.1
13.0
—
—
—
0
0
10
17
6.13
4.18
2.3
10.8
6.16
6.56
mmol/l
—
10
12
132
1023
1.88
4.14
5.1
3.2
—
—
—
0
0
68
430
1.89
4.10
2.4
3.3
2.36
2.36
mmol/l
0.07
62
391
69
439
1.88
4.08
4.6
2.9
—
—
—
0
0
102
733
1.81
4.07
6.0
4.5
0.00
0.00
estimate
-0.00
29
138
169
1431
2.27
4.05
6.2
4.1
1.84
1.80
mu/l
0.15
156
1333
23
95
2.61
3.98
7.6
2.0
—
—
—
0
0
103
746
1.80
3.97
4.6
3.2
0.00
0.00
estimate
-0.00
26
132
163
1367
2.11
3.91
5.0
4.7
39.05
38.82
mmol/mol
0.09
153
1297
61
381
1.87
3.78
5.3
3.4
0.00
0.00
estimate
-0.00
29
133
88
616
1.77
3.75
3.8
3.0
5.75
5.84
ph
—
6
66
61
383
1.86
3.71
4.1
2.8
—
—
—
0
0
25
112
2.41
3.66
7.4
2.0
—
—
—
0
0
19
75
2.70
3.58
4.6
4.4
—
—
—
0
0
36
191
2.08
3.54
1.4
1.4
493.33
442.86
titre
—
6
42
43
245
1.97
3.48
2.1
1.7
163889315.17
456.93
pmol/l
0.49
36
219
55
342
1.84
3.42
5.0
3.2
1.02
1.02
kg/l
0.14
11
45
55
346
1.82
3.29
4.5
3.2
—
—
—
0
0
12
34
3.69
3.26
2.0
1.9
6.39
0.80
ug/l
0.44
12
34
25
120
2.24
3.15
7.5
2.0
—
—
—
0
0
34
185
2.01
3.12
2.1
2.3
13.54
15.37
umol/l
0.57
29
173
25
121
2.22
3.09
7.5
2.0
—
—
—
0
0
25
121
2.22
3.09
7.5
2.0
—
—
—
0
0
181
1620
2.44
3.09
24.2
11.2
23.76
22.58
mg/l
0.19
152
1222
49
306
1.80
2.98
2.3
1.8
2.83
2.91
mg/l
0.08
43
261
22
103
2.28
2.94
2.0
2.4
15849.27
2256.60
u/l
—
6
44
24
119
2.16
2.80
7.8
1.7
—
—
—
0
0
36
209
1.88
2.74
4.0
2.7
2.79
1.91
e6/l
0.29
21
103
15
61
2.58
2.69
1.9
2.1
—
—
—
0
0
32
181
1.92
2.63
2.3
1.9
—
—
—
0
0
30
168
1.93
2.54
2.5
1.5
—
—
—
0
0
39
240
1.78
2.47
2.7
2.5
120.22
120.33
ug/g
0.00
32
193
89
680
1.56
2.43
3.1
2.5
106.42
97.40
ug/l
0.15
84
638
52
351
1.65
2.37
6.5
6.6
—
—
—
0
0
21
106
2.10
2.36
4.0
4.2
0.80
0.53
%
—
10
36
141
1204
1.60
2.30
5.1
3.0
42.74
42.31
u/l
0.03
136
1152
22
115
2.03
2.26
5.5
4.3
1.10
0.76
%
—
10
42
28
161
1.86
2.20
2.3
2.3
23.38
26.57
%
0.45
21
134
58
411
1.58
2.16
1.4
1.3
1.75
1.28
u/ml
0.27
15
113
18
90
2.10
2.08
1.1
1.1
—
6.20
—
0
5
23
127
1.92
2.04
6.6
3.6
—
—
—
0
0
88
691
1.49
2.03
14.4
8.5
0.00
0.00
e9/l
0.50
76
558
165
1484
1.69
1.98
4.9
3.7
5.93
5.81
mmol/l
0.37
156
1387
5
11
4.63
1.95
2.8
2.0
—
—
—
0
0
29
176
1.76
1.93
3.3
2.9
4.54
10.80
umol/l
1.79
24
152
58
424
1.52
1.86
4.9
3.1
8.87
8.52
mmol/l
0.17
51
372
73
560
1.48
1.85
2.0
1.9
—
—
—
0
0
20
109
1.93
1.85
5.7
4.4
0.00
0.22
%
—
8
36
5
12
4.24
1.83
1.2
1.4
—
—
—
0
0
8
29
2.83
1.81
2.0
1.4
—
—
—
0
0
8
29
2.83
1.81
1.1
1.4
—
—
—
0
0
6
18
3.40
1.76
7.2
2.2
91.35
91.99
%
—
6
18
15
75
2.08
1.75
3.0
2.7
0.23
0.10
e6/l
0.45
15
69
25
151
1.75
1.70
2.4
2.5
24.45
31.96
u/l
1.47
20
128
18
100
1.88
1.59
1.6
1.4
—
—
—
0
0
5
15
3.39
1.53
1.0
1.5
—
—
—
0
0
50
369
1.48
1.51
1.3
1.4
2.23
2.29
g/l
0.13
35
232
9
37
2.50
1.50
1.6
1.5
0.50
0.41
nmol/l
—
9
28
45
327
1.49
1.46
3.5
3.0
—
—
—
0
0
6
22
2.78
1.44
1.8
2.3
7.42
7.28
u/ml
—
6
22
170
1572
1.59
1.44
4.8
4.1
2.68
2.84
mmol/l
1.83
157
1478
12
60
2.06
1.41
3.4
2.6
—
—
—
0
0
12
60
2.06
1.41
1.1
3.5
—
—
—
0
0
182
1716
1.80
1.37
22.0
10.3
—
—
—
0
0
10
47
2.19
1.36
1.4
1.3
—
—
—
0
0
16
91
1.83
1.33
5.4
2.1
—
—
—
0
0
9
43
2.14
1.32
1.2
1.2
—
—
—
0
0
6
24
2.55
1.31
1.2
1.1
—
—
—
0
0
5
118
0.41
1.29
3.2
4.8
2.08
9.48
ug/l
—
5
97
8
36
2.27
1.26
1.3
1.3
—
—
—
0
0
8
38
2.15
1.20
4.3
4.4
58.00
58.05
%
—
8
38
35
252
1.47
1.20
1.3
1.2
16.12
26.46
iu/ml
—
9
87
61
489
1.36
1.15
1.8
1.6
—
—
—
0
0
17
104
1.69
1.13
6.2
4.4
0.00
0.03
%
—
6
30
167
1559
1.47
1.12
4.5
3.8
4.59
4.70
mmol/l
0.86
156
1475
11
59
1.92
1.09
2.0
1.2
—
—
—
0
0
162
1510
1.41
1.04
4.1
3.4
1.35
1.30
mmol/l
0.33
150
1418
16
99
1.67
1.03
2.9
4.5
—
—
—
0
0
32
234
1.44
1.02
1.6
1.2
16.89
4.81
u/ml
0.35
11
96
15
92
1.68
1.00
1.1
1.2
—
30.16
—
0
5
10
54
1.90
0.98
1.3
2.1
1.45
1.30
g/l
—
10
47
9
50
1.84
0.98
2.2
2.6
23.11
22.39
s
—
9
44
6
118
0.49
0.97
1.5
1.8
—
—
—
0
0
18
264
0.65
0.95
1.4
1.4
—
—
—
0
0
8
44
1.85
0.87
1.3
1.6
—
—
—
0
0
165
1556
1.37
0.86
4.4
3.8
1.41
1.42
mmol/l
0.19
154
1466
15
97
1.59
0.84
1.4
1.3
29.34
392.66
u/ml
0.83
15
86
15
100
1.54
0.75
1.1
1.2
—
—
—
0
0
7
38
1.87
0.74
4.3
4.2
5.07
4.39
e9/l
—
7
38
33
259
1.33
0.72
1.9
1.6
—
—
—
0
0
190
1851
1.74
0.70
34.1
16.3
40.51
41.17
%
0.82
177
1757
42
345
1.28
0.66
2.2
2.7
361.65
4971.50
umol/l
1.26
34
308
0
21
0.00
0.60
0.0
4.1
—
19.52
—
0
21
190
1857
1.65
0.60
33.7
16.1
6.92
6.60
e9/l
1.38
182
1806
190
1855
1.68
0.60
33.7
16.1
4.56
4.61
e12/l
0.75
184
1807
46
389
1.24
0.57
1.7
1.7
1.52
1.42
mmol/l
0.41
40
337
9
65
1.40
0.51
4.0
2.4
0.63
0.71
%
—
9
65
12
84
1.46
0.50
1.6
1.1
—
—
—
0
0
22
173
1.31
0.49
1.6
1.4
—
—
—
0
0
189
1851
1.52
0.47
33.9
16.1
261.98
252.39
e9/l
1.09
183
1807
22
176
1.28
0.44
1.4
1.5
—
—
—
0
0
5
31
1.63
0.43
1.4
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
0
15
0.00
0.41
0.0
2.5
—
—
—
0
0
12
88
1.39
0.41
1.0
1.0
—
—
—
0
0
0
17
0.00
0.41
0.0
4.6
—
2.45
—
0
17
8
60
1.35
0.41
1.1
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
197.52
—
0
18
54
481
1.17
0.40
2.0
2.0
—
—
—
0
0
25
297
0.82
0.37
1.5
1.8
—
—
—
0
0
6
41
1.48
0.36
1.8
2.7
—
—
—
0
0
6
44
1.37
0.34
2.8
2.7
3.47
5.12
umol/l
—
6
32
8
62
1.30
0.28
3.0
2.9
—
—
—
0
0
20
173
1.17
0.22
1.5
1.2
—
—
—
0
0
12
98
1.24
0.21
3.2
3.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
12.87
—
0
10
40
366
1.12
0.21
3.8
3.7
5.77
12.26
mg/mmol
0.85
35
242
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
6
50
1.21
0.20
1.3
1.2
—
—
—
0
0
6
51
1.18
0.19
6.3
4.3
—
—
—
0
0
10
81
1.25
0.19
1.5
1.3
—
—
—
0
0
5
68
0.73
0.17
1.8
1.4
—
—
—
0
0
5
68
0.73
0.17
1.8
1.4
—
—
—
0
0
5
69
0.72
0.17
1.8
1.5
—
—
—
0
0
12
141
0.84
0.17
1.2
1.4
—
—
—
0
0
14
160
0.87
0.14
1.9
1.5
—
—
—
0
0
40
377
1.08
0.12
1.7
1.7
—
—
—
0
0
16
145
1.11
0.09
1.3
1.2
—
—
—
0
0
5
48
1.04
0.09
8.8
8.6
—
—
—
0
0
6
54
1.11
0.09
2.3
1.4
—
—
—
0
0
10
91
1.10
0.04
1.0
1.1
—
—
—
0
0
67
658
1.03
0.03
2.6
2.5
—
—
—
0
0
36
350
1.03
0.03
3.2
3.1
58.94
80.08
mg/l
0.20
30
238
19
199
0.95
0.03
2.1
1.9
—
—
—
0
0
24
246
0.97
0.00
2.7
2.4
0.76
0.63
ug/l
0.37
17
120
24
245
0.98
0.00
1.5
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
2.0
—
3.03
—
0
6
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
0
7
0.00
0.00
0.0
28.6
—
98.86
—
0
7
0
6
0.00
0.00
0.0
1.2
—
8.77
—
0
6
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
156.33
—
0
6
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
3.9
—
7.12
—
0
8
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
5
54
0.92
-0.00
1.4
2.0
—
4.89
—
0
20
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
9
99
0.90
-0.00
1.3
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
3.1
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_TOXIC_EFFECT_CORROSIVE_SUBST – Toxic effect of corrosive substances

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).